...
首页> 外文期刊>Annals of Surgery >Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
【24h】

Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.

机译:术中边缘阳性的近端胆管的额外切除可提高肝门胆管癌患者的生存率。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: To assess the survival benefit of additional resection of an intraoperative positive proximal bile duct margin (BD(Marg)) in patients undergoing hepatectomy for hilar cholangiocarcinoma (HCCA). SUMMARY BACKGROUND DATA: Intraoperative evidence of invasive cancer at the proximal (BD(Marg)) is associated with a dismal survival irrespective of whether a final negative (BD(Marg)) is achieved with an additional resection. METHODS: Clinicopathologic, operative, and survival data of consecutive patients undergone curative intent hepatectomy with bile duct resection (n = 75) for HCC (1989-2010) were analyzed. RESULTS: Frozen-section examination of the proximal (BD(Marg)) revealed invasive cancer in 19 of the 67 patients. After additional resection, which was possible in 18 cases, a secondary R0 (BD(Marg)) resection was achieved in 15 patients (83.3%), with 2 of these having, at final pathology, positive radial and distal margins. Eventually, 8 patients were classified as R1 and 67 as R0 (54 primary R0 and 13 secondary R0). Median survival of patients who had a secondary R0 resection (30.6 months) was similar to that of primarily R0-resected patients (29.3 months) and significantly better than that of R1 patients (14.9 months) (P = 0.026). Median time to recurrence and site of recurrence were similar in R0 patients independently of the performance of an additional resection. The incidence of biliary fistula was significantly increased (44.4% vs 17.5%; P = 0.02) in patients necessitating a margin re-resection. CONCLUSIONS: Additional resection of a positive proximal (BD(Marg)) , albeit associated with an increased risk of biliary fistula, offers a significant survival benefit and should be attempted whenever possible.
机译:目的:评估在肝门部胆管癌(HCCA)肝切除术患者中术中阳性近端胆管切缘(BD(Marg))的进一步切除的生存获益。摘要背景资料:不管是否通过额外的切除术最终达到阴性(BD(Marg)),近端浸润性癌(BD(Marg))的术中证据均与生存不良有关。方法:分析1989年至2010年连续接受根治性肝切除术并胆管切除术(n = 75)的连续患者的临床病理,手术和生存数据。结果:近端冰冻切片检查(BD(Marg))显示67例患者中有19例为浸润性癌。经过额外的切除术(可能在18例中),在15例患者(83.3%)中进行了二次R0(BD(Marg))切除,其中2例在最终病理学上显示radial骨和远端边缘阳性。最终,有8位患者被分类为R1,而67位被分类为R0(54位主要R0和13位次要R0)。接受R0二次切除的患者(30.6个月)的中位生存期与主要接受R0切除的患者(29.3个月)相似,并且显着优于R1切除患者(14.9个月)(P = 0.026)。 R0患者的中位复发时间和复发部位相似,而与再次切除无关。需要进行切缘切除术的患者胆道瘘的发生率显着增加(44.4%比17.5%; P = 0.02)。结论:额外切除阳性近端(BD(Marg)),尽管与胆瘘的风险增加有关,但可显着提高生存率,应尽一切可能进行尝试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号